Cite
MLA Citation
Y Komaki et al.. “Meta‐Analysis of the Risk of Immune‐Related Adverse Events With Anticytotoxic T‐Lymphocyte‐Associated Antigen 4 and Antiprogrammed Death 1 Therapies.” Clinical pharmacology & therapeutics, vol. 103, no. 2, 2018, pp. 318–331. http://access.bl.uk/ark:/81055/vdc_100055540179.0x00005b